摘要
目的 分析沙库巴曲缬沙坦钠治疗慢性心衰对患者心功能的改善作用。方法 以2022年1—6月在门诊就诊的40例慢性心衰患者作为研究对象,均接受常规利尿强心治疗、美托洛尔治疗以及沙库巴曲缬沙坦钠治疗。对比治疗后1个月、3个月、半年、1年的临床症状体征及心功能指标变化、NT-proBNP水平、6分钟步行实验结果以及焦虑、抑郁、生活质量评分。结果 治疗后1个月、3个月、半年、1年,40例患者的各项心功能指标、NT-proBNP水平、6分钟步行实验结果,以及焦虑评分、抑郁评分、生活质量评分都逐渐改善(P<0.05)。结论 慢性心衰在常规利尿强心等治疗基础上,应用沙库巴曲缬沙坦钠治疗可以积极改善患者的心功能,缓解症状,改善患者生活质量,改善预后,安全有效。
Objective To analyze improvement effect of sacubitril valsartan sodium on heart function of patients with chronic heart failure.Methods The paper chose 40 patients with chronic heart failure in outpatient clinic from January 2022 to June 2022 as study subjects,treated with routine diuretic and cardiac strengthening treatment,metoprolol treatment,and sacubitril valsartan sodium treatment.Changes in clinical symptoms,signs,cardiac function indicators,NT proBNP levels,6-minute walk test results,anxiety,depression,and life quality scores at 1 month,3 months,6 months,and 1 year after treatment were compared.Results After 1 month,3 months,6 months,and 1 year of treatment,various cardiac function indicators,NT proBNP levels,6-minute walking test results,anxiety scores,depression scores,and life quality scores of 40 cases gradually improved(P<0.05).Conclusion Based on routine diuretic and cardiac strengthening treatments,sacubitril valsartan sodium can actively improve heart function,alleviate symptoms,improve life quality and prognosis of chronic heart failure,which is safe and effective.
作者
焦婷
JIAO Ting(Chaoyang District Shuangjing Health Service Center,Beijing,100022)
出处
《智慧健康》
2024年第6期68-71,共4页
Smart Healthcare
关键词
慢性心衰
沙库巴曲缬沙坦钠
心功能
治疗效果
Chronic heart failure
Sacubitril valsartan sodium
Heart function
Curaitve effect
